A new study introduces a series of fluorescent dyes that blink on and off naturally without harsh chemicals or intense light, enabling scientists to use super-resolution microscopy to observe cancer-related processes — such as how cells migrate and respond to their environment — inside living cells in real time. Catherine Galbraith, Ph.D., says, “By figuring out how to use the dyes systematically, matching each dye’s blinking properties to the right imaging context, Brian and I made them useful to observe dynamic biological processes as they happen, and answer the kinds of questions cancer researchers are asking.”

The OHSU Knight Cancer Institute’s Precision Biofabrication Hub receives more than $9.2 million in NIH funding across three grants to develop “organs-on-a-chip” — small devices containing living human cells that mimic bone, blood vessels and other tissues — to study how cancers such as osteosarcoma and prostate cancer grow, spread, and respond to treatment in bone, with the goal of developing more effective therapies. Luiz Bertassoni, D.D.S., Ph.D., says, “We are leveraging technologies developed here to study complex, aggressive cancers in ways that simply weren’t possible before.”

A federal district judge rules that Oregon's Reproductive Health Equity Act violates the First Amendment religious freedom rights of Oregon Right to Life, prompting state leaders to vow they would appeal the decision and pursue every legal avenue to defend access to reproductive health care, while noting that coverage for Oregonians remains unchanged pending a written opinion. Maria Rodriguez, M.D., says, “One of the main barriers to health care in this country is still cost. And so while we will continue to be available at OHSU and across the state of Oregon with our partners providing access to essential abortion services, when it's not affordable for people, it's out of reach.”

A federal district judge rules that Oregon's Reproductive Health Equity Act violates the First Amendment religious freedom rights of Oregon Right to Life, prompting state leaders to vow they would appeal the decision and pursue every legal avenue to defend access to reproductive health care, while noting that coverage for Oregonians remains unchanged pending a written opinion. Maria Rodriguez, M.D., says, “One of the main barriers to health care in this country is still cost. And so while we will continue to be available at OHSU and across the state of Oregon with our partners providing access to essential abortion services, when it's not affordable for people, it's out of reach.”

The Oregonian reports that OHSU has received $6 million in new funding from the National Institutes of Health to develop tiny, lab-built systems that mimic the function of human tissues and spread of disease. Luiz Bertassoni, Ph.D., says, “These devices allow us to generate that complexity in the lab and get at important questions we cannot study in patients."

OHSU researchers have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer -- and identified a promising strategy to overcome that resistance. Katelyn Byrne, Ph.D., says, “This approach could make resistant tumors more permissive, meaning they could respond to immunotherapy when they previously didn’t."

The OHSU Knight Cancer Institute’s Precision Biofabrication Hub receives more than $9.2 million in NIH funding across three grants to develop “organs-on-a-chip” — small devices containing living human cells that mimic bone, blood vessels and other tissues — to study how cancers such as osteosarcoma and prostate cancer grow, spread, and respond to treatment in bone, with the goal of developing more effective therapies. Luiz Bertassoni, D.D.S., Ph.D., says, “We are leveraging technologies developed here to study complex, aggressive cancers in ways that simply weren’t possible before.”

A federal district judge rules that Oregon's Reproductive Health Equity Act violates the First Amendment religious freedom rights of Oregon Right to Life, prompting state leaders to vow they would appeal the decision and pursue every legal avenue to defend access to reproductive health care, while noting that coverage for Oregonians remains unchanged pending a written opinion. Maria Rodriguez, M.D., says, “One of the main barriers to health care in this country is still cost. And so while we will continue to be available at OHSU and across the state of Oregon with our partners providing access to essential abortion services, when it's not affordable for people, it's out of reach.”

A federal district judge rules that Oregon's Reproductive Health Equity Act violates the First Amendment religious freedom rights of Oregon Right to Life, prompting state leaders to vow they would appeal the decision and pursue every legal avenue to defend access to reproductive health care, while noting that coverage for Oregonians remains unchanged pending a written opinion. Maria Rodriguez, M.D., says, “One of the main barriers to health care in this country is still cost. And so while we will continue to be available at OHSU and across the state of Oregon with our partners providing access to essential abortion services, when it's not affordable for people, it's out of reach.”

A federal district judge rules that Oregon's Reproductive Health Equity Act violates the First Amendment religious freedom rights of Oregon Right to Life, prompting state leaders to vow they would appeal the decision and pursue every legal avenue to defend access to reproductive health care, while noting that coverage for Oregonians remains unchanged pending a written opinion. Maria Rodriguez, M.D., says, “One of the main barriers to health care in this country is still cost. And so, while we will continue to be available at OHSU and across the state of Oregon with our partners providing access to essential abortion services, when it's not affordable for people, it's out of reach.”